Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OMNIlife science is a medical technology company specializing in robotic-assisted orthopedic solutions for hip and knee replacement surgery. The company's flagship OMNIBotics platform utilizes proprietary bone-morphing technology and robotic instrumentation to provide surgeons with real-time data and precise alignment during procedures. By integrating advanced software with specialized implants, OMNI aims to improve patient outcomes and surgical efficiency in joint reconstruction. Their technology allows for customized ligament balancing, which is a critical factor in patient satisfaction following knee replacement. Following its acquisition by Corin Group in 2019, the company's technologies have been integrated into a broader digital ecosystem for personalized orthopedic care. OMNI continues to operate as a key innovation hub for robotic surgery within the global Corin organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMNIlife science.